LAD328

· Almirall, S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAD328, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa [Phase 2]